Asgard Therapeutics scures €6 million from Novo Holdings, Boehringer Ingelheim Venture Fund and Industrifonden.

Biotech Health services Pharma

Investments

08 November 2021

Asgard Therapeutics (company)

Biotech Health services Pharma

Total investments received (USD): 39.24m

Round value (USD): 6.87m

Round investors: Boehringer Ingelheim Venture Fund Industrifonden Novo Seeds

Industry: Biotech Health services Pharma

Biotech Health services

Investments 20 March 2022

Biotech Health services Manufacturing Pharma

Investments 15 December 2021

Biotech Health services

Investments 09 November 2021

Biotech Health services Manufacturing Pharma

Investments 20 September 2021